Implications of adopting new WHO guidelines for antiretroviral therapy initiation in Ethiopia
Elke Konings, Yirga Ambaw, Katherine Dilley, Peter Gichangi, Tesfaye Arega & Bud Crandall
Volume 90, Number 9, September 2012, 659-663
Table 1. CD4+ T-lymphocyte (CD4+) profile of patients with human immunodeficiency virus (HIV) before starting antiretroviral therapy (pre ART) or while on ART, 19 health centres, Ethiopia, May 2010
| Current guidelines |
New WHO guidelines |
|||||
|---|---|---|---|---|---|---|
| No. of pre-ART patients |
No. of patients on ART | No. of patients eligible for ART under new WHO guidelines [A + C = D] |
Percentage of patients not eligible for ART under previous guidelines [A/D] |
Per cent increase in total no. of patients on ART [(D − C)/C] |
||
| with a CD4+ count > 200 but ≤ 350 cells/mm3, asymptomatic [A] |
with a CD4+ count > 350 cells/mm3, asymptomatic [B] |
|||||
| with a CD4+ count ≤ 200 cells/mm3, symptomatic (stages III, IV) [C] |
||||||
| 1057 | 1445 | 3583 | 4640 | 23 | 30 | |
WHO, World Health Organization.